Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Johnson & Johnson talc...

    Johnson & Johnson talc issue: NGO writes to National Human Rights Commission

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-12-25T09:35:19+05:30  |  Updated On 17 Aug 2021 12:18 PM IST

    The NGO has said that it has sought to draw the "urgent attention" of the rights panel, towards the relevance of the report on the baby talc powder manufactured by global major Johnson & Johnson.


    New Delhi: Amid reports that a product of a leading firm allegedly contained cancer-causing asbestos, a city-based NGO has written to the NHRC, seeking its intervention in the matter. In a letter written to the National Human Rights Commission (NHRC), Toxics Watch Alliance (TWA) has cited media reports and claimed that a national laboratory in Lucknow has "corroborated" the findings.


    The NGO has said that it has sought to draw the "urgent attention" of the rights panel, towards the relevance of the report on the baby talc powder manufactured by global major Johnson & Johnson.


    "In view of the above, I seek Commission's urgent intervention to recommend complete stoppage of ongoing exposure of Indians to carcinogenic asbestos fibres-contaminated talc powder of Johnson & Johnson and other companies in India," the NGO's director Gopal Krishna was quoted as saying in the statement.


    Read Also: Compensation formula: Delhi HC junks Johnson and Johnson's plea


    Following orders of Drug Controller General of India (DCGI), drug inspectors have seized samples of various baby products of Johnson and Johnson from wholesalers, retailers and distributors across the country on Friday, an official had said.


    The regulator on Thursday had ordered the firm to not use talc raw material from its Mulund plant in Mumbai and Baddi unit in Himachal Pradesh for production till further direction.


    The inspectors collected samples of Johnson and Johnson's baby powder from both the plants, amid reports that the product allegedly contained cancer-causing asbestos.


    The company said on Wednesday they were "fully cooperating" with the CDSCO by providing tests and samples, and said Johnson & Johnson's baby powder is asbestos-free and doesn't cause cancer.


    Also Read: Another trouble for J&J: CDSCO seize samples of baby products for testing
    cancerCDSCODCGIDrug Controller General of IndiaGopal KrishnaJohnson & JohnsonletterNational Human Rights CommissionNGONHRCtalcToxics Watch AllianceTWA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok